Vasculitides induced by TNFα antagonists: a study in 39 patients in France
- 1 December 2006
- journal article
- Published by Elsevier BV in Joint Bone Spine
- Vol. 73 (6), 710-713
- https://doi.org/10.1016/j.jbspin.2006.02.010
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- Immunology of Cutaneous Vasculitis Associated with both Etanercept and InfliximabScandinavian Journal of Immunology, 2005
- Etanercept plus Standard Therapy for Wegener's GranulomatosisThe New England Journal of Medicine, 2005
- Cutaneous vasculitis and glomerulonephritis in a patient taking the anti-TNFα agent etanercept for rheumatoid arthritisJoint Bone Spine, 2004
- Anti–tumor necrosis factor therapy in patients with difficult to treat Takayasu arteritisArthritis & Rheumatism, 2004
- Hypersensitivity Vasculitis with Leukocytoclastic Vasculitis Secondary to InfliximabJournal of Clinical Gastroenterology, 2003
- Anti-tumour necrosis factor therapy associated with cutaneous vasculitisRheumatology, 2002
- Effectiveness of TNF-alpha blockade with infliximab in refractory Wegener's granulomatosisRheumatology, 2002
- Efficacy of the anti-TNF-alpha antibody infliximab against refractory systemic vasculitides: an open pilot study on 10 patientsRheumatology, 2002
- Lethal medium-vessel panarteritis mimicking deep sepsis following etanercept and minocycline therapy in a patient with severe rheumatoid arthritisRheumatology, 2002
- Etanercept and infliximab associated with cutaneous vasculitisRheumatology, 2002